Vimarsana
Biggest News Aggregation in the World

Page 7 - Class Actions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Class Actions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Class Actions Today - Breaking & Trending Today

What junior doctors' unpaid overtime tells us about the toxic side of medicine - Vimarsana News

What junior doctors' unpaid overtime tells us about the toxic side of medicine

Overworking junior doctors has been normalised for decades. And we all suffer.

Client Alert: Insuring Against Recent Trend Of Antitrust Actions Targeting Pricing Algorithms - Antitrust, EU Competition - Vimarsana News

Client Alert: Insuring Against Recent Trend Of Antitrust Actions Targeting Pricing Algorithms - Antitrust, EU Competition

Following a 2022 ProPublica article reporting on the use of a third-party software to inflate rents in "a new kind of cartel," a new wave of antitrust enforcement...

Source: mondaq.com
April 2024 Business Litigation Report - Trials & Appeals & Compensation - Vimarsana News

April 2024 Business Litigation Report - Trials & Appeals & Compensation

Legal professional privilege is a longstanding and fundamental principle of English law, and yet it finds itself before the Courts with such frequency that it is also one that is continually evolving.

Source: mondaq.com
Class Action Settlement Considerations For Defense Counsel - Class Actions - Vimarsana News

Class Action Settlement Considerations For Defense Counsel - Class Actions

David Ross (Partner-Washington, DC) and Daniel Coffman (Associate, Washington, DC) collaborated on an article titled "Class Action Settlement Considerations for Defense Counsel,".

Source: mondaq.com
Second Circuit Affirms District Court's Summary Judgment Dismissal Of Securities Fraud Class Action Against Pharmaceutical Company - Securities - Vimarsana News

Second Circuit Affirms District Court's Summary Judgment Dismissal Of Securities Fraud Class Action Against Pharmaceutical Company - Securities

On April 15, 2024, the United States Court of Appeals for the Second Circuit affirmed in a non-precedential summary order the summary judgment dismissal of securities fraud claims against a pharmaceutical company ...

Source: mondaq.com